-
ARMP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Armata Pharmaceuticals (ARMP)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 22.62 mm | 22.62 mm | 22.62 mm | 22.62 mm | 22.62 mm | 22.62 mm |
Cash burn (monthly) | 3.09 mm | 596.75 k | 3.25 mm | 3.46 mm | 2.95 mm | 3.14 mm |
Cash used (since last report) | 12.44 mm | 2.40 mm | 13.11 mm | 13.93 mm | 11.91 mm | 12.67 mm |
Cash remaining | 10.18 mm | 20.22 mm | 9.52 mm | 8.69 mm | 10.72 mm | 9.95 mm |
Runway (months of cash) | 3.3 | 33.9 | 2.9 | 2.5 | 3.6 | 3.2 |
13F holders | Current |
---|---|
Total holders | 16 |
Opened positions | 2 |
Closed positions | 12 |
Increased positions | 2 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 1.59 bn |
Total shares | 65.89 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
INVA Innoviva | 64.18 mm | $264.41 mm |
Corvesta | 633.94 k | $202.00 k |
Synthetic Genomics | 516.98 k | $2.19 mm |
Vanguard | 225.29 k | $533.93 mm |
Geode Capital Management | 107.07 k | $253.81 mm |
Edgewood Management | 100.00 k | $237.00 mm |
Renaissance Technologies | 46.50 k | $110.20 mm |
SeaCrest Wealth Management | 34.95 k | $82.84 mm |
BlackRock | 23.80 k | $56.41 mm |
NTRS Northern Trust | 19.27 k | $45.68 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Oct 24 | David Duane House | Stock Options Common Stock | Grant | Acquire A | No | No | 2.32 | 75,000 | 174.00 k | 75,000 |
14 Mar 24 | Deborah Birx | Common Stock | Grant | Acquire A | No | No | 0 | 60,000 | 0.00 | 260,000 |
14 Mar 24 | Deborah Birx | Stock Options Common Stock | Grant | Acquire A | No | No | 3.38 | 240,000 | 811.20 k | 240,000 |
14 Mar 24 | Kramer Robin | Stock Options Common Stock | Grant | Acquire A | No | No | 3.38 | 54,343 | 183.68 k | 94,009 |
14 Mar 24 | Kramer Robin | Stock Options Common Stock | Grant | Acquire A | No | No | 3.38 | 39,666 | 134.07 k | 39,666 |